Nrf2 protects against TWEAK-mediated skeletal muscle wasting

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Al Sawaf, Othman ^a   Fragoulis, Athanassios ^a   Rosen, Christian ^a   Kan, Yuet Wai ^b   Sönmez, Tolga Taha ^c   Pufe, Thomas ^a   Wruck, Christoph Jan ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NFE2L2 PROTEIN, MOUSE; PRIMER DNA; TNFSF12 PROTEIN, MOUSE; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR;

ANIMAL; APOPTOSIS; ARTICLE; C57BL MOUSE; CELL LINE; ENZYME LINKED IMMUNOSORBENT ASSAY; KNOCKOUT MOUSE; MOUSE; MUSCLE ATROPHY; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; SKELETAL MUSCLE;

ANIMALS; APOPTOSIS; BASE SEQUENCE; CELL LINE; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SKELETAL; MUSCULAR ATROPHY; NF-E2-RELATED FACTOR 2; POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTORS;

EID: 84892146006     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep03625     Document Type: Article

References (31)

1. Sharma, R. & Anker, S. D. Cytokines, apoptosis and cachexia: the potential for TNF antagonism. Int J Cardiol 85, 161-171 (2002).
2. Bhatnagar, S., Mittal, A., Gupta, S. K. & Kumar, A. TWEAK causes myotube atrophy through coordinated activation of ubiquitin-proteasome system, autophagy, and caspases. J Cell Physiol 227, 1042-1051, DOI:10.1002/jcp.22821 (2012).
3. Dogra, C. et al. TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine. FASEB J 21, 1857-1869, DOI:10.1096/fj.06-7537com (2007). (Pubitemid 46855631)
4. Mittal, A. et al. Genetic ablation of TWEAK augments regeneration and postinjury growth of skeletal muscle in mice. Am J Pathol 177, 1732-1742, DOI:10.2353/ajpath.2010.100335 (2010).
5. Wasserman, W. W. & Fahl, W. E. Functional antioxidant responsive elements. Proc Natl Acad Sci USA 94, 5361-5366 (1997). (Pubitemid 27214788)
6. Wakabayashi, N., Slocum, S. L., Skoko, J. J., Shin, S. & Kensler, T. W. When NRF2 talks, who's listening? Antioxid Redox Signal 13, 1649-1663, DOI:10.1089/ars.2010.3216 (2010).
7. Kim, J., Cha, Y. N. & Surh, Y. J. A protective role of nuclear factor-erythroid 2-related factor-2 (Nrf2) in inflammatory disorders. Mutat Res 690, 12-23, DOI:10.1016/j.mrfmmm.2009.09.007 (2010).
8. Ichihara, S. et al. Ablation of the transcription factor Nrf2 promotes ischemiainduced neovascularization by enhancing the inflammatory response. Arterioscler Thromb Vasc Biol 30, 1553-1561, DOI:10.1161/ATVBAHA.110.204123 (2010).
9. Thimmulappa, R. K. et al. Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J Clin Invest 116, 984-995, DOI:10.1172/jci25790 (2006).
10. Khor, T. O. et al. Nrf2-deficient mice have an increased susceptibility to dextran sulfate sodium-induced colitis. Cancer Res 66, 11580-11584, DOI:10.1158/0008-5472.can-06-3562 (2006). (Pubitemid 46094166)
11. Osburn, W. O. et al. Increased colonic inflammatory injury and formation of aberrant crypt foci in Nrf2-deficient mice upon dextran sulfate treatment. Int J Cancer 121, 1883-1891, DOI:10.1002/ijc.22943 (2007). (Pubitemid 47463150)
12. Bhatnagar, S. & Kumar, A. The TWEAK-Fn14 system: breaking the silence of cytokine-induced skeletal muscle wasting. Curr Mol Med 12, 3-13 (2012).
13. Wruck, C. J. et al. Kavalactones protect neural cells against amyloid beta peptideinduced neurotoxicity via extracellular signal-regulated kinase 1/2-dependent nuclear factor erythroid 2-related factor 2 activation. Mol Pharmacol 73, 1785-1795, DOI:10.1124/mol.107.042499 (2008). (Pubitemid 351724366)
14. Winkles, J. A. The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting. Nat Rev Drug Discov 7, 411-425, DOI:10.1038/nrd2488 (2008). (Pubitemid 351619113)
15. Dohi, T., Kawashima, R. & Burkly, L. C. Role of TWEAK (TNF-alpha-Like Weak Inducer of Apoptosis) in Intestinal Inflammation and Tissue Repair. Gastroenterology 136, A255-A255 (2009).
16. Baxter, F. O. et al. IKKbeta/2 induces TWEAK and apoptosis in mammary epithelial cells. Development 133, 3485-3494, DOI:10.1242/dev.02502 (2006). (Pubitemid 44501850)
17. De Ketelaere, A. et al. Involvement of GSK-3beta in TWEAK-mediated NFkappaB activation. FEBS Lett 566, 60-64, DOI:10.1016/j.febslet.2004.04.041 (2004). (Pubitemid 38625933)
18. Chicheportiche, Y. et al. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. Journal of Biological Chemistry 272, 32401-32410, DOI: 10.1074/jbc.272.51.32401 (1997). (Pubitemid 28011923)
19. Faraonio, R. et al. p53 suppresses theNrf2-dependent transcription of antioxidant response genes. J Biol Chem 281, 39776-39784, DOI:10.1074/jbc. M605707200 (2006). (Pubitemid 46041781)
20. Kwak, M. K. et al. Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival. J Biol Chem 278, 8135-8145, DOI:10.1074/jbc.M211898200 (2003). (Pubitemid 36800555)
21. Li, W. et al. Activation of Nrf2-antioxidant signaling attenuates NFkappaBinflammatory response and elicits apoptosis. Biochem Pharmacol 76, 1485-1489, DOI:10.1016/j.bcp.2008.07.017 (2008).
22. Folmer, F. et al. Inhibition of TNFalpha-induced activation of nuclear factor kappaB by kava (Piper methysticum) derivatives. Biochem Pharmacol 71, 1206-1218, DOI:10.1016/j.bcp.2005.12.032 (2006). (Pubitemid 43357901)
23. Li, H. et al. Tumor necrosis factor-related weak inducer of apoptosis augments matrix metalloproteinase 9 (MMP-9) production in skeletal muscle through the activation of nuclear factor-kappaB-inducing kinase and p38 mitogen-activated protein kinase: a potential role of MMP-9 in myopathy. J Biol Chem 284, 4439-4450, DOI:10.1074/jbc.M805546200 (2009).
24. Yu, R. et al. Activation of mitogen-activated protein kinase pathways induces antioxidant response element-mediated gene expression via a Nrf2-dependent mechanism. J Biol Chem 275, 39907-39913, DOI:10.1074/jbc. M004037200 (2000). (Pubitemid 32064611)
25. Kweider, N. et al. Interplay between vascular endothelial growth factor (VEGF) and nuclear factor erythroid 2-related factor-2 (Nrf2): implications for preeclampsia. J Biol Chem 286, 42863-42872, DOI:10.1074/jbc.M111.286880 (2011).
26. Wruck, C. J. et al. Luteolin protects rat PC12 and C6 cells against MPP1induced toxicity via an ERK dependent Keap1-Nrf2-ARE pathway. J Neural Transm Suppl 57-67 (2007).
27. Bryan, H. K., Olayanju, A., Goldring, C. E. & Park, B. K. The Nrf2 cell defence pathway: Keap1-dependent and-independent mechanisms of regulation. Biochem Pharmacol 85, 705-717, DOI:10.1016/j.bcp.2012.11.016 (2013).
28. Mittal, A. et al. The TWEAK-Fn14 system is a critical regulator of denervationinduced skeletal muscle atrophy in mice. J Cell Biol 188, 833-849, DOI:10.1083/jcb.200909117 (2010).
29. Sönmez, T. T. et al. A Novel Laser-Doppler Flowmetry Assisted Murine Model of Acute Hindlimb Ischemia-Reperfusion for Free Flap Research. PLOS ONE 8, e66498 (2013).
30. Chan, K., Lu, R., Chang, J. C. & Kan, Y. W. NRF2, amember of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development. Proc Natl Acad Sci USA 93, 13943-13948 (1996). (Pubitemid 26424225)
31. Jahn, L., Sadoshima, J. & Izumo, S. Cyclins and cyclin-dependent kinases are differentially regulated during terminal differentiation of C2C12muscle cells. Exp Cell Res 212, 297-307 (1994). (Pubitemid 24216705)